This content is machine translated Modern asthma therapies New data on biologics and triple therapy The treatment of severe asthma is increasingly moving towards individualized and low-steroid treatment concepts. Current developments in biologics and modern inhaled therapy strategies were highlighted at the DGP Congress 2026....…
View Post 6 min This content is machine translated Hand and Finger Injuries Preventing Permanent Functional Limitations Over the years, a paradigm shift has taken place in modern hand surgery. The focus is on conservative treatment, which emphasizes early restoration of mobility under the guidance of an...…
View Post 7 min This content is machine translated Actinic keratoses Targeted Treatment of Multiple AK Lesions—Balancing Efficacy and Convenience Actinic keratoses occur singly or in confluent patches on sun-exposed areas of the skin. Clinical and/or dermatoscopic diagnosis can be supported by non-invasive diagnostic tools such as confocal microscopy and...…
View Post 7 min This content is machine translated Obesity: A Multimodal and Interdisciplinary Approach New Swiss Clinical Practice Guideline Provides Guidance The guidelines developed by Swiss professional associations (Swiss Obesity Clinical Practice Guidance) contain evidence-based recommendations for the diagnosis and treatment of obesity, with a focus on improving health, quality of...…
View Post 7 min This content is machine translated cSCC: Personalizing Treatment Strategies and Follow-up Care Plans Comprehensive risk stratification is no simple matter: what’s new? Cutaneous squamous cell carcinoma (cSCC) is currently the second most common type of skin cancer, and the number of cases continues to rise. While surgical resection alone is considered the...…
View Post 3 min This content is machine translated Psoriasis Research: What's in the Pipeline? Highly selective oral TYK inhibitors in Phase III Envudeucitinib and Zasocitinib are oral, allosteric tyrosine kinase 2 (TYK2) inhibitors currently being evaluated in clinical trials for plaque psoriasis. The interim results presented during the Late-Breaking Research sessions at...…
View Post 5 min This content is machine translated Highlights from the AAD Annual Meeting Atopic Dermatitis: Interesting News on Drug Candidates in Phase III At the 2026 Annual Meeting of the American Academy of Dermatology (AAD), the latest study data on amlitelimab and rademikibart, among other topics, were presented during Late-Breaking Research sessions. The...…
View Post 6 min This content is machine translated Autoimmune Liver Diseases Innovative Treatment Approaches for PBC, PSC, and AIH: What’s New? PPAR agonists as second-line therapy have proven effective in primary biliary cholangitis (PBC) not only in clinical trials but also in real-world settings, as recent research findings show. In primary...…
View Post 5 min This content is machine translated Psoriasis in the Age of Precision Medicine Systemic Therapy for Patients with Comorbidities: What Is the Best Choice? Psoriasis is a chronic inflammatory systemic disease often associated with comorbidities, a fact that must be taken into account during treatment. Particular attention should be paid to psoriatic arthritis (PsA),...…
View Post 4 min This content is machine translated MASH Pharmacotherapies as “Game Changers”—What Are the Upcoming Challenges? Two drug therapy options—semaglutide (s.c.) and resmetirom (oral)—are now approved in the EU and the U.S. for the treatment of MASH. This is a major breakthrough, especially since, for a...…
View Post 5 min This content is machine translated Older patients with atopic dermatitis Why the Use of Biologics Is Recommended In light of demographic trends, an increase in the prevalence of atopic dermatitis is also being observed among the elderly population. Tailored treatment plans take into account a wide range...…
